Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
26 March, 2017 20:24 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
RCap completes transfer of commercial finance biz to subsidiary - 24-Mar-2017 18:46
TCS, LIBA to launch management program on Business Analytics - 24-Mar-2017 11:56
Asian Oilfield wins LoA for contract worth Rs 1.08 bn - 24-Mar-2017 11:50
Asian Oilfield wins LoA for contract worth Rs 1.08 bn - 24-Mar-2017 11:50
NTPC plans to achieve 32 GW installed capacity via renewable sources by 2032 - 24-Mar-2017 10:47
RCF issues commercial paper worth Rs 1.50 bn - 24-Mar-2017 10:21
Ujaas Energy bags order from Indraprastha Power - 24-Mar-2017 09:29
NHPC inks purchase pacts with Tata Power - 24-Mar-2017 09:13
Siemens bags RE order worth Rs 1.87 bn - 24-Mar-2017 09:09
Bharti Airtel to acquire Tikona Networks' 4G biz for Rs 16 bn - 24-Mar-2017 08:52
Lupin receives USFDA nod for generic inhalation solution - 23-Mar-2017 16:00
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer